Akoustis Technologies Stock Forecast, Price & News

Akoustis Technologies (NASDAQ:AKTS) Frequently Asked Questions

Is Akoustis Technologies a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Akoustis Technologies stock.
View analyst ratings for Akoustis Technologies or view top-rated stocks.

What stocks does MarketBeat like better than Akoustis Technologies?

Wall Street analysts have given Akoustis Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Akoustis Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Akoustis Technologies' next earnings date?

Akoustis Technologies is scheduled to release its next quarterly earnings announcement on Monday, November 1st 2021.
View our earnings forecast for Akoustis Technologies.

How were Akoustis Technologies' earnings last quarter?

Akoustis Technologies, Inc. (NASDAQ:AKTS) posted its quarterly earnings results on Sunday, August, 29th. The technology company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.01. The technology company had revenue of $2.20 million for the quarter, compared to analysts' expectations of $2.50 million. Akoustis Technologies had a negative trailing twelve-month return on equity of 42.85% and a negative net margin of 667.21%. The firm's revenue for the quarter was up 501.1% compared to the same quarter last year.
View Akoustis Technologies' earnings history.

How has Akoustis Technologies' stock price been impacted by Coronavirus?

Akoustis Technologies' stock was trading at $5.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AKTS stock has increased by 64.8% and is now trading at $8.75.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for AKTS?

5 analysts have issued 12-month price targets for Akoustis Technologies' shares. Their forecasts range from $14.00 to $20.00. On average, they expect Akoustis Technologies' stock price to reach $17.40 in the next year. This suggests a possible upside of 98.9% from the stock's current price.
View analysts' price targets for Akoustis Technologies or view top-rated stocks among Wall Street analysts.

Who are Akoustis Technologies' key executives?

Akoustis Technologies' management team includes the following people:

• Jeffrey B. Shealy, President, Chief Executive Officer & Director (LinkedIn Profile)
• Robert Dry, Vice President-Operations & Test
• Kenneth Boller, Chief Financial Officer & Controller (LinkedIn Profile)
• David M. Aichele, Executive Vice President-Business Development (LinkedIn Profile)
• Rohan Houlden, Chief Product Officer (LinkedIn Profile)

Who are some of Akoustis Technologies' key competitors?

Some companies that are related to Akoustis Technologies include Infinera (INFN), Avaya (AVYA), Telkom SA SOC (TLKGY), Plantronics (POLY), AudioCodes (AUDC), NETGEAR (NTGR), ADTRAN (ADTN), Clearfield (CLFD), DZS (DZSI), Sunworks (SUNW), Exlites Holdings International (EXHI), Communications Systems (JCS), Minim (MINM), Franklin Wireless (FKWL) and Altigen Communications (ATGN).
View all of AKTS's competitors.

What other stocks do shareholders of Akoustis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Square (SQ), Editas Medicine (EDIT), Marvell Technology (MRVL), Alibaba Group (BABA), Invitae (NVTA), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP) and JD.com (JD).

What is Akoustis Technologies' stock symbol?

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

How do I buy shares of Akoustis Technologies?

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Akoustis Technologies' stock price today?

One share of AKTS stock can currently be purchased for approximately $8.75.

How much money does Akoustis Technologies make?

Akoustis Technologies has a market capitalization of $449.59 million and generates $6.62 million in revenue each year. The technology company earns $-44.16 million in net income (profit) each year or ($0.78) on an earnings per share basis.

How many employees does Akoustis Technologies have?

Akoustis Technologies employs 99 workers across the globe.

What is Akoustis Technologies' official website?

The official website for Akoustis Technologies is www.akoustis.com.

Where are Akoustis Technologies' headquarters?

Akoustis Technologies is headquartered at 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078.

How can I contact Akoustis Technologies?

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at (704) 997-5735 or via email at [email protected].